Campus News

Liver Researcher Named Keystone Fellow

Liver Researcher Named Keystone Fellow

Esperanza Arias-Perez, Pharm.D., Ph.D., assistant professor of medicine and of pathology at Einstein, has been named a 2023 Keystone Symposia Fellow. She is one of only 10 investigators nationwide selected for the honor, which recognizes rising talent in biological and biomedical research. 

The competitive one-year program is designed to provide early-career researchers from underrepresented and other disadvantaged backgrounds with the skills they need to successfully pursue leadership and decision-making roles in academic, industry, and government research sectors.

Dr. Arias-Perez, who is a member of the Marion Bessin Liver Research Center at Einstein, Einstein’s Institute for Aging Research, and Montefiore Einstein Cancer Center, focuses on liver-related disease, ranging from nonalcoholic steatohepatitis to liver cancer, with a special interest in the molecular basis underlying clinical disparities. 

Dr. Arias-Perez received her Ph.D. from the School of Medicine at the Autonomous University of Madrid (Spain) and has worked in clinical research at Ferring Pharmaceuticals and at Pfizer. As a Fulbright postdoctoral fellow in the lab of Ana Maria Cuervo, M.D., Ph.D., professor of developmental and molecular biology and of medicine at Einstein, Dr. Arias-Perez studied mammalian autophagy in the context of aging and age-related diseases.

More From Einstein

Class of 2024 Celebrates Match Day
Einstein Community Enjoys Pi Day
Graduate Students Win Marmur Award
Empowering Einstein Women in Science
Einstein Secures $192M in NIH Grants
Training the Next Cancer Researchers
Bringing a Novel Drug to Market
A Promise to Rwandan Genocide Survivors